Warning Letter Close-Outs – October 2019
The US FDA released two device-related close-out letters in October.
You may also be interested in...
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
The US FDA released one device-related close-out letter in November.